Market Access

Pharmaceutical and biotechnology manufactures need effective market access strategies that get them the best reimbursement possible for their asset while keeping those assets affordable for payers, so that patients have access to new, effective therapies as soon as possible.

  • Defining strategy

  • Consultancy, development and submission of HTA applications

  • Competition evaluation (pricing, reimbursement and HTA)

  • Submission of pricing applications

  • Monitoring of submitted applications

  • Review of Prescribing and Reimbursement Protocols

  • Ensuring communication between the company and authorities

  • Stakeholder mapping

  • Relevant policy assessment

  • HTA trainings/courses

  • Patients support programs